641881099	641881099	CD	B-NP	O
|	|	NN	I-NP	O
CMC	CMC	NN	I-NP	O
|	|	NN	I-NP	O
16803216	16803216	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6209471	6209471	CD	B-NP	O
|	|	CC	I-NP	O
7/20/2005	7/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Volume	Volume	NN	I-NP	I-protein
overload	overload	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/7/2005	2/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/3/2005	5/3/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
EWALD	EWALD	NN	B-NP	O
,	,	,	O	O
DESHAWN	DESHAWN	NN	B-NP	O
C	C	NN	I-NP	O
856-99-02-2	856-99-02-2	CD	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/13/05	8/13/05	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LANDRES	LANDRES	NNP	B-NP	O
,	,	,	O	O
ISIAH	ISIAH	NNP	B-NP	O
L	L	NNP	I-NP	O
P.	P.	NNP	I-NP	O
DORSEY	DORSEY	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
300	300	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	VBD	B-VP	I-protein
325	325	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
CALCIUM	CALCIUM	NNP	I-NP	I-protein
CARBONATE	CARBONATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
ELEMENTAL	ELEMENTAL	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
PEPCID	PEPCID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FAMOTIDINE	FAMOTIDINE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
TACROLIMUS	TACROLIMUS	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
;	;	:	O	O
2	2	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
August	August	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Separate	Separate	NNP	I-NP	O
antacids	antacid	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
grapefruit	grapefruit	NN	B-NP	O
juice	juice	NN	I-NP	O
BACTRIM	BACTRIM	NN	I-NP	O
SS	SS	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	O
/	/	SYM	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	O
SI	SI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
3x/Week	3x/Week	NN	I-NP	O
M-W-F	M-W-F	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
give	give	VB	B-VP	O
on	on	IN	B-PP	O
M	M	NNP	B-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
CELLCEPT	CELLCEPT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NNP	I-NP	O
MOFETIL	MOFETIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
AMARYL	AMARYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GLIMEPIRIDE	GLIMEPIRIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
While	While	IN	B-SBAR	O
NPO	NPO	NNP	B-NP	B-protein
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
While	While	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Elstad	Elstad	NNP	I-NP	O
9/24	9/24	CD	I-NP	O
at	at	IN	B-PP	O
9AM	9AM	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Volume	Volume	NN	B-NP	O
overload	overload	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Volume	Volume	NNP	I-NP	O
overload	overload	VBD	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
pain	pain	NN	I-NP	O
hypotension	hypotension	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
kidney	kidney	NN	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
AAA	AAA	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
abdominal	abdominal	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
open	open	JJ	I-NP	O
chole	chole	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cholelithiasis	cholelithiasis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Replacement	Replacement	NN	B-NP	O
of	of	IN	B-PP	O
Pacer	Pacer	NN	B-NP	B-protein
generator	generator	NN	I-NP	I-protein
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Dx	Dx	NN	B-NP	O
:	:	:	O	O
Volume	Volume	NN	B-NP	B-protein
overload	overload	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
Increasing	Increase	VBG	B-VP	O
edema	edema	NN	B-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
*****	*****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
M	M	NN	I-NP	O
ESRD	ESRD	NN	I-NP	O
,	,	,	O	O
LURT	LURT	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
10/20	10/20	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
with	with	IN	B-PP	O
3wks	3wk	NNS	B-NP	O
increasing	increase	VBG	B-VP	O
edema	edema	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
20lb	20lb	NN	B-NP	B-protein
weight	weight	NN	I-NP	I-protein
gain	gain	NN	I-NP	I-protein
.	.	.	O	O

SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Has	Have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
consumed	consume	VBD	B-VP	O
2	2	CD	B-NP	O
cans	can	NNS	I-NP	O
of	of	IN	B-PP	O
salted	salted	JJ	B-NP	O
cashews	cashew	NNS	I-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
VSS	VSS	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat-97	sat-97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
RR-20	RR-20	NN	B-NP	B-protein
.	.	.	O	O

Bibasilar	Bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S3	S3	NN	B-NP	B-protein
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
ab	ab	NN	I-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

LE	LE	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
B/L	B/L	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	B-NP	O
Labs/Studies	Labs/Study	NNS	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
Cr-1	Cr-1	NN	I-NP	B-protein
.7	.7	CD	I-NP	I-protein
,	,	,	O	O
otherwise	otherwise	JJ	B-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
V-Pacer	V-Pacer	NN	I-NP	O
,	,	,	O	O
Prolonged	Prolonged	NNP	B-NP	O
QT	QT	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
St-T	St-T	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

CXR-Mild	CXR-Mild	NNP	B-NP	O
Pul	Pul	NNP	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
BNP-350	BNP-350	NN	B-NP	B-protein
.	.	.	O	O

*****	*****	SYM	O	O
Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
74M	74M	NNP	B-NP	O
ESRD	ESRD	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
LURP	LURP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/20	10/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
medication	medication	NN	B-NP	O
and	and	CC	I-NP	O
diet	diet	NN	I-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
decompensated	decompensate	VBN	I-NP	O
CHF	CHF	NN	I-NP	B-protein
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
no	no	DT	I-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
or	or	CC	I-NP	O
respiratory	respiratory	JJ	I-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
ACS	ACS	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
daiuresed	daiuresed	JJ	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
5L	5L	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
imoprovement	imoprovement	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
Cr-1	Cr-1	NN	B-NP	B-protein
.7	.7	CD	I-NP	I-protein
.	.	.	O	O

FK-506	FK-506	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
seemed	seem	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
3mg	3mg	CD	B-NP	O
to	to	TO	B-PP	O
2mg/d	2mg/d	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
admittion	admittion	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
uneventful	uneventful	JJ	I-NP	O
generator	generator	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
pacer	pacer	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
Please	Please	NNP	I-NP	O
refer	refer	VBP	B-VP	O
to	to	TO	I-VP	O
separate	separate	VB	I-VP	O
note	note	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
it	it	PRP	B-NP	O
easy	easy	JJ	B-ADJP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
stick	stick	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
daily	daily	JJ	I-NP	O
Lasix	Lasix	NNP	I-NP	O
80mg	80mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
!	!	.	O	O
!	!	.	O	B-cell_line
!	!	.	O	B-protein
Please	Please	NNP	B-NP	I-protein
write	write	VB	B-VP	O
down	down	RP	B-PRT	O
your	your	PRP$	B-NP	B-cell_type
daily	daily	JJ	I-NP	I-cell_type
weights	weight	NNS	I-NP	I-cell_type
until	until	IN	B-PP	I-cell_type
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Klym	Klym	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Consider	Consider	VB	B-VP	O
ACE-I	ACE-I	NN	B-NP	B-protein
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
control	control	VB	I-VP	O
his	his	PRP$	B-NP	O
BP	BP	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ORIHUELA	ORIHUELA	NNP	B-NP	O
,	,	,	O	O
MERVIN	MERVIN	NNP	B-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CZ26	CZ26	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/13/05	8/13/05	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
05	05	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

